Clinical Trial Update: Pioglitazone Treatment for Hyperglycemic Acute Ischemic Stroke [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating pioglitazone for hyperglycemic acute ischemic stroke has been terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hyperglycemia
• Stroke

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Stroke, Acute, Hyperglycemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-09-15